Adalat: Advanced Blood Pressure Control with Nifedipine
| Product dosage: 20mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.50 | $45.29 (0%) | 🛒 Add to cart |
| 120 | $0.43 | $60.38 $51.32 (15%) | 🛒 Add to cart |
| 180 | $0.35 | $90.57 $63.40 (30%) | 🛒 Add to cart |
| 270 | $0.30 | $135.86 $81.51 (40%) | 🛒 Add to cart |
| 360 | $0.27
Best per pill | $181.14 $97.62 (46%) | 🛒 Add to cart |
Adalat, containing the active ingredient nifedipine, is a trusted calcium channel blocker prescribed for the management of hypertension and angina. This medication works by relaxing and widening blood vessels, allowing blood to flow more easily and reducing the heart’s workload. It is a cornerstone in cardiovascular therapy, offering a targeted mechanism of action for sustained clinical efficacy. Available in various formulations, including extended-release tablets, Adalat provides flexible dosing to meet individual patient needs and long-term therapeutic goals.
Features
- Active ingredient: Nifedipine (30 mg, 60 mg, or 90 mg extended-release tablets)
- Drug class: Calcium channel blocker (dihydropyridine subclass)
- Administration: Oral tablet, taken once or twice daily as prescribed
- Formulation: GITS (Gastrointestinal Therapeutic System) for controlled 24-hour release
- Prescription status: Rx-only medication
- Manufacturer: Bayer AG (originator); multiple generic versions available
- FDA approval: Initially approved in 1981; multiple formulations and indications since
Benefits
- Effectively lowers high blood pressure, reducing the risk of stroke, heart attack, and kidney damage.
- Prevents angina (chest pain) by improving blood flow to the heart muscle and decreasing cardiac oxygen demand.
- Provides 24-hour blood pressure control with once-daily dosing in extended-release formulations, supporting adherence.
- Exhibits a favorable side effect profile compared to some other antihypertensive classes, with a low incidence of metabolic disturbances.
- Can be used as monotherapy or in combination with other antihypertensive agents for synergistic effects.
- Helps maintain vascular health by reducing arterial stiffness and improving endothelial function.
Common use
Adalat is primarily indicated for the management of essential hypertension (high blood pressure) and chronic stable angina pectoris. It is also used off-label for certain cases of Raynaud’s phenomenon and preterm labor under strict obstetric supervision. The medication is suitable for adult patients, including the elderly, though dose adjustments may be necessary based on clinical response and tolerability. It is often prescribed when first-line agents like ACE inhibitors or diuretics are insufficient or not tolerated.
Dosage and direction
The dosage of Adalat must be individualized based on the patient’s clinical condition and response to therapy. For hypertension, the usual starting dose is 30 mg or 60 mg once daily, which may be titrated upward over 7- to 14-day intervals. The maximum recommended dose is 90 mg daily. For angina, the initial dose is typically 30 mg or 60 mg once daily, with titration based on symptom control. Tablets should be swallowed whole with a glass of water, without crushing, chewing, or dividing, to maintain the extended-release properties. Administration with or without food is acceptable, though consistency is advised. Dose adjustments are necessary in patients with hepatic impairment.
Precautions
Patients should be monitored regularly for blood pressure and heart rate response, especially during initial titration. Caution is advised in patients with heart failure, severe aortic stenosis, or severe obstructive coronary artery disease due to potential negative inotropic effects. Abrupt discontinuation should be avoided, as it may lead to rebound hypertension or angina. Use with caution in elderly patients and those with impaired liver function; dose reduction may be necessary. Patients should avoid grapefruit juice, as it can increase nifedipine plasma concentrations. Peripheral edema is a common side effect and should be differentiated from worsening heart failure.
Contraindications
Adalat is contraindicated in patients with known hypersensitivity to nifedipine or any component of the formulation. It must not be used in patients with cardiogenic shock, clinically significant aortic stenosis, or during acute myocardial infarction (especially within the first 2 weeks). Concomitant use with strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir) is contraindicated due to the risk of severe hypotension. The immediate-release formulation is contraindicated for hypertensive crises due to the risk of precipitous blood pressure drops and reflex tachycardia.
Possible side effect
Common side effects include peripheral edema (swelling of ankles/feet), headache, dizziness, flushing, and fatigue. Less frequently, patients may experience palpitations, nausea, constipation, or muscle cramps. Serious but rare adverse effects include hypotension, syncope, worsening angina, heart failure, and marked liver enzyme elevations. Allergic reactions such as rash or pruritus may occur. Extended-release formulations generally exhibit a lower incidence of side effects compared to immediate-release forms. Most side effects are dose-dependent and may diminish with continued use or dose adjustment.
Drug interaction
Nifedipine is primarily metabolized by CYP3A4, making it susceptible to interactions with inhibitors and inducers of this enzyme. Strong inhibitors (e.g., clarithromycin, itraconazole) can significantly increase nifedipine levels, raising the risk of hypotension. Inducers (e.g., rifampin, carbamazepine) may reduce efficacy. Concurrent use with beta-blockers may increase the risk of heart failure or severe hypotension. Additive hypotensive effects are possible with other antihypertensives, nitrates, or phosphodiesterase-5 inhibitors. Nifedipine may increase levels of digoxin, quinidine, or tacrolimus, requiring monitoring.
Missed dose
If a dose is missed, it should be taken as soon as remembered on the same day. If it is near the time for the next dose, the missed dose should be skipped, and the regular dosing schedule resumed. Doubling the dose to make up for a missed one is not recommended, as it may increase the risk of adverse effects such as hypotension or dizziness. Patients should be advised to maintain a consistent dosing routine, ideally taking the medication at the same time each day, to ensure stable blood pressure control.
Overdose
Symptoms of nifedipine overdose may include severe hypotension, bradycardia or tachycardia, syncope, metabolic acidosis, and hyperglycemia. In severe cases, cardiac arrest or shock may occur. Management is supportive and includes cardiovascular monitoring, Trendelenburg positioning, IV fluids, and vasopressors (e.g., calcium gluconate, dopamine) as needed. Gastric lavage may be considered if ingestion was recent; activated charcoal can be administered. Hemodialysis is not effective due to high protein binding. Symptomatic treatment should be provided in a critical care setting.
Storage
Adalat tablets should be stored at room temperature (15–30°C or 59–86°F) in their original container, protected from light and moisture. Keep out of reach of children and pets. Do not store in bathrooms or near sinks where humidity is high. Discard any unused medication after the expiration date printed on the packaging. Do not flush medications down the toilet or pour into a drain unless instructed to do so; consult a pharmacist for proper disposal methods.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read here. Dosage and indications may vary; always follow the prescribing information provided by your healthcare professional.
Reviews
Clinical studies and patient reports consistently affirm Adalat’s efficacy in blood pressure and angina management. Many users note significant improvement in symptoms and quality of life, with the once-daily formulation praised for convenience. Some report side effects like edema or headache, though these often subside with continued use or dose adjustment. Physicians appreciate its reliability and well-established safety profile, though individual response may vary. Overall, Adalat remains a widely respected option in cardiovascular pharmacotherapy.